Decreased nocturnal secretion of melatonin in drug-free schizophrenics: No change after subchronic treatment with antipsychotics

Neuropsychobiology

Volumn 36, Issue 4, 1997, Pages 159-163

  Monteleone, Palmiero ^a   Natale, Mariantonietta ^a   La Rocca, Antonietta ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Circadian rhythm; Melatonin; Neuroleptics; Schizophrenia

Indexed keywords

MELATONIN; NEUROLEPTIC AGENT; PINEAL BODY HORMONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; PINEAL BODY; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; TIME;

ADULT; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; SCHIZOPHRENIA;

EID: 0030783368     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119377     Document Type: Article

References (26)

1. Mclsaae WM: A biochemical concept of mental disease. Postgrad Med 1961:30:111-118.
2. Miles A, Grey JE: Melatonin and schizophrc-nia-a biochemical link? in Miles A, Plutterich DHS. Thompson C (eds): Melatonin: Clinical Perspectives. Oxford. Oxford University Press. 1988. pp 243-252.
3. Sandyk R, Kay SR: Pineal melatonin in schizophrenia: A review and hypothesis. Schizophr Bull 1990:16:653-662.
4. Reiter RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. EndocrRev 1991;12:151-180.
5. Hanssen T: Propanolol and schizophrenia. Arch Gen Psychiatry 1980;37:685-690.
6. Ferrier IN, Arendt J, Johnstone EC, Crow TJ: Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clin Endocrinol 1982:17:181-187.
7. Ferrier IN, Johnstone EC, Crow TJ, Arendt J: Melatonin/cortisol ratio in psychiatric illness. Lancet 1982;i: 1070.
8. Fanget F, Ciaustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat J: Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry 1989:25:499-501.
9. Steiner M: Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci 1990:240:21-27.
10. Beckman H, Wetterberg L, Gattaz WF: Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry Res 1984:11:107-110.
11. Rao ML. Gross G, Strebel B, Braunig P, Huber G, Klostcrkotter J: Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and ncurolcptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 1990:34:243-257.
12. Robinson S, Rosea P, Durst R, Shai U, Ghinea C, Schmidt U, Nir I: Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. Acta Psychiat Scand 1991:84:221-224.
13. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ: Depressed nocturnal levels in drug-free paranoid schizophrenics. Schizophr Res 1992:7:77-84.
14. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Braunig P, Marler M: Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151-163.
15. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G: A comprehensive psychopatho-logical rating scale. Acta Psychiat Scand 1978; 271(suppl):63-69.
16. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, The University of Iowa, 1984.
17. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, The University of Iowa, 1983.
18. Reiter RJ: Action spectra, dose-response relationships. and temporal aspects of light's effects on the pineal gland. Ann NY Acad Sci 1985;453:215-230.
19. Miles A, Philbrick D, Tidmarsh SF, Shaw DM: Direct radioimmunoassay of melatonin in saliva. Clin Chern 1985;31:1412-1413.
20. Hartley R, Smith JA: The activation of pineal hydroxyindole-O-methyltransferasc by psy-chomimetic drugs. J Pharm Pharmacol 1973; 25:751-752.
21. Jones RL, McGeer PL, Greiner AC: Metabolism of exogenous melatonin in schizophrenic and non-schizophrenic subjects. Clin Chirn Acta 1969:26:281-286.
22. van Kämmen DP, Gelernter J: Biochemical instability in schizophrenia I: The norepinephrine system: in Meitzer HY (ed): Psychopharmacology. The Third Generation of Progress. New York. Raven Press. 1987. pp 745-751.
23. Roth BL, Meitzer HY: The role of serotonin in schizophrenia; in Bloom FE, Kupfer DJ (eds): Psychopharmacology. The Fourth Generation of Progress. New York. Raven Press, 1995, pp 1215-1228.
24. Smith JA, Bamest JL, Mee TJ: The effects of neuroleptic drags on serum and cerebrospinal fluid melatonin concentrations in psychiatric subjects. J Pharm Pharmacol 1979:31:246-249.
25. Ozaki Y, Linch HJ, Wurtman RJ: Melatonin in rat pineal, plasma, and urine: 24-hour rhyth-micity and effect of chlorpromazine. Endocrinology 1976;98:1418-1424.
26. Govitrapong P, Hama Y, Pfeiffer R, Ebadi M: Status of dopamine in bovine pineal glands and the stimulation of N-acetyltransferase activity by D-2-dopaminergic receptor agonists in the rat pineal glands in culture. J Pineal Res 1989; 6:17-31.